Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...

Professor Diana Egerton-Warburton outlines the benefits of a Learning Health System (LHS) approach, which integrates stakeholder input, research, and data-driven practices to enhance healthcare qualit ...

In the midst of the ongoing Ebola outbreak in the Democratic Republic of the Congo, and in the absence of antiviral medications for the disease, the World Health Organization (WHO) has issued updated ...

Design Therapeutics has its proprietary GeneTAC platform, which gives them a small-molecule way to target repeat-expansion ...

This is the story of a nurse in Michigan who decided to become the person she always knew she could be after experiencing the ...

The WHO has issued its first comprehensive guidelines for managing Ebola and Marburg diseases, stressing early supportive care as Africa battles an ongoing Bundibugyo Ebola outbreak.

The next issue of Sunrise will soon be in your inbox. We encountered an issue signing you up. Please try again Interested in ...

Manikomycin is being hailed as a potential breakthrough in the fight against antibiotic-resistant bacteria. Perhaps it is.

"We’re at the point where we can actually cure a large number of patients," the centre's director says.

Bad trades, poor coaching and terrible communication all conspired to undercut a championship environment. There was plenty of blame on all sides.

Weeks before first responders fought valiantly to save lives at Bondi Beach in Sydney in December last year, an international ...

Glass bone disease is more than just a plot device in a movie, it's a real but very rare disorder that affects tens of ...